Ropes & Gray Earns 12 Shortlists in Prestigious Life Sciences Awards

Ropes & Gray was named a finalist in 12 categories for the ninth annual LMG Life Sciences Americas Awards, a remarkable illustration of the firm’s excellence across every facet of the life sciences industry.

The firm was shortlisted across a range of specialties representing key business concerns of life sciences companies and their collaborators, including corporate law, licensing & collaboration, FDA regulation, government investigations, and antitrust. Five individual attorneys were named finalists in their respective practice areas, and two Ropes & Gray-led matters are in contention for “Impact Case of the Year.”

The firm is being considered for:

• Corporate Firm of the Year
• Licensing & Collaboration Firm of the Year
• Regulatory Firm of the Year
• Government Investigations Firm of the Year
• Antitrust Firm of the Year

Individual finalists include:

• Marc Rubenstein (Corporate Attorney of the Year)
• Hannah Freeman (Licensing & Collaboration Attorney of the Year)
• Greg Levine (Regulator Attorney of the Year)
• Brien O’Connor (Government Investigations Attorney of the Year)
• Mark Popofsky (Antitrust Practitioner of the Year)

“Impact Case of the Year” contenders are:

• Neurocrine Biosciences and Takeda’s $2 billion collaboration
  
• Litigation brought before the California Supreme Court in which Ropes & Gray represented a global life sciences company

The LMG Life Sciences Americas Awards recognize the top law firms, lawyers and in-house counsel specializing in the life sciences industry, with winners selected based on case evidence, peer feedback, client feedback and a commanding recognition of the industry. Honorees will be celebrated during the annual awards event on September 22, 2021.